Stockscreener 앱 받기
5.3912
4.09%
-0.2288
전일 마감가:
$5.62
열려 있는:
$5.67
하루 거래량:
727.33K
Relative Volume:
0.80
시가총액:
$334.28M
수익:
-
순이익/손실:
$-96.66M
주가수익비율:
-2.5075
EPS:
-2.15
순현금흐름:
$-83.73M
1주 성능:
+10.22%
1개월 성능:
+65.85%
6개월 성능:
-55.31%
1년 성능:
-49.48%
1일 변동 폭
$5.33
$5.69
1주일 범위
$4.85
$5.735
52주 변동 폭
$2.86
$16.62
올레마 Stock (OLMA) Company Profile
명칭
Olema Pharmaceuticals Inc
전화
(415) 651-3316
주소
780 BRANNAN STREET, SAN FRANCISCO
OLMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
5.39 | 334.28M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
503.45 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
608.62 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
654.05 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.28 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.09 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
올레마 Stock (OLMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-02 | 개시 | Goldman | Buy |
| 2024-01-30 | 개시 | Citigroup | Buy |
| 2023-07-21 | 개시 | Oppenheimer | Outperform |
| 2023-05-05 | 개시 | CapitalOne | Overweight |
| 2023-02-22 | 개시 | Credit Suisse | Outperform |
| 2022-07-06 | 재개 | Canaccord Genuity | Buy |
| 2022-06-09 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 개시 | H.C. Wainwright | Neutral |
| 2021-12-07 | 재개 | Cowen | Outperform |
| 2020-12-14 | 개시 | Canaccord Genuity | Buy |
| 2020-12-14 | 개시 | Cowen | Outperform |
| 2020-12-14 | 개시 | JP Morgan | Overweight |
| 2020-12-14 | 개시 | Jefferies | Buy |
모두보기
올레마 주식(OLMA)의 최신 뉴스
Renaissance Technologies LLC Buys 127,900 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Boxer Capital Management LLC Invests $3.79 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
HC Wainwright Reaffirms Buy Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OLMA Stock News - GuruFocus
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Breast Cancer Drug Developer Olema Awards 104,400 Stock Options to Key New Hires - Stock Titan
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Legal & General Group Plc - Defense World
A look into Olema Pharmaceuticals Inc (OLMA)’s deeper side - Sete News
Renaissance Technologies LLC Has $917,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight - GlobeNewswire Inc.
Can you now get a good deal on Olema Pharmaceuticals Inc’s shares? - uspostnews.com
Walleye Capital LLC Invests $391,000 in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Financial Snapshot: Analyzing Olema Pharmaceuticals Inc (OLMA)’s Key Ratio Metrics - DWinneX
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by JPMorgan Chase & Co. - Defense World
Olema Pharmaceuticals’ (OLMA) Buy Rating Reaffirmed at HC Wainwright - Defense World
Market Recap Check: Olema Pharmaceuticals Inc (OLMA)’s Negative Finish at 3.76, Up/Down -8.52 - DWinneX
Silverarc Capital Management LLC Reduces Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Avoro Capital Advisors LLC Takes $9.63 Million Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Geode Capital Management LLC Decreases Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Bain Capital Life Sciences Investors LLC Invests $43.55 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals Says OP-3136 Molecule Shows Anti-Tumor Activity in Preclinical Models - marketscreener.com
Olema Oncology Announces New Preclinical Data for OP-3136 - GlobeNewswire
Cancer Breakthrough: New Drug OP-3136 Achieves 28-Day Tumor Regression in Multiple Cancer Types - Stock Titan
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Update - MarketBeat
Financial Analysis: Olema Pharmaceuticals Inc (OLMA)’s Ratios Unveil Key Insights - DWinneX
Wall Street Analysts Think Olema Pharmaceuticals (OLMA) Could Surge 433.13%: Read This Before Placing a Bet - Yahoo Finance
Olema Pharmaceuticals Inc (OLMA)’s results reveal risk - uspostnews.com
Alliancebernstein L.P. Has $1.83 Million Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Vanguard Group Inc. Has $15.65 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals Inc (OLMA) Stock: From Low to High in 52 Weeks - investchronicle.com
Franklin Resources Inc. Has $1.60 Million Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Vanguard Group Inc. Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Alliancebernstein L.P. Has $1.83 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
American Century Companies Inc. Reduces Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Wellington Management Group LLP Boosts Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
KLP Kapitalforvaltning AS Takes Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
올레마 (OLMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
0.30%
자본화:
|
볼륨(24시간):